Difference between revisions of "Invasive breast cancer"
Jump to navigation
Jump to search
(→HER2 scoring: revised cut point) |
|||
| Line 296: | Line 296: | ||
*‡ The cut point was 10%, changed to 30% and then changed back to 10%.<ref name=pmid24382093/> | *‡ The cut point was 10%, changed to 30% and then changed back to 10%.<ref name=pmid24382093/> | ||
ISH based testing:<ref | ISH based testing:<ref>URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/breast_biomarker_template.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/breast_biomarker_template.pdf]. Accessed on: October 7, 2014.</ref> | ||
{| class="wikitable sortable" | {| class="wikitable sortable" | ||
! Result | ! Result | ||
| Line 303: | Line 303: | ||
|- | |- | ||
| Positive | | Positive | ||
| >2. | | >=2.0 HER2/CEP17 | ||
| >6.0 copies of HER2/cell | | >=6.0 copies of HER2/cell | ||
|- | |- | ||
| Equivocal | | Equivocal | ||
| | | <2.0 HER2/CEP17 (required) | ||
| 4.0-6.0 copies of HER2/cell | | 4.0-6.0 copies of HER2/cell | ||
|- | |- | ||
| Negative | | Negative | ||
| < | | <2.0 HER2/CEP17 | ||
| <4.0 copies of HER2/cell | | <4.0 copies of HER2/cell | ||
|} | |} | ||